Myovant Sciences Ltd. MYOV
$ 26.98
-0.04%
Quarterly report 2022-Q4
added 01-26-2023
Country |
USA |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
CEO |
Dr. Lynn Seely |
Employees in the company |
214 |
Shares |
90 M |
Market Cap[1] |
$ 2.62 B |
EBITDA (LTM) |
$ -248 M |
P/E (LTM) |
-8.28 |
P/S (LTM) |
3.76 |
EPS (LTM) |
-3.26 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.